Knowledge and Proportion of COVID-19 Vaccination and Associated Factors Among Cancer Patients Attending Public Hospitals of Addis Ababa, Ethiopia, 2021: A Multicenter Study

References

• Organization. WH. COVID-19 Weekly Epidemiological Update. Geneva.; 2021.
   Google Scholar
• Gilbert M, Pullano G, Pinotti F. Preparedness and vulnerability of African countries against importations of COVID-19: a modeling study. Lancet. 2020;395(10227):871–877. doi:10.1016/S0140-6736(20)30411-632087820
   PubMed Web of Science ®Google Scholar
• Zikargae Z. COVID-19 in Ethiopia: assessment of How the Ethiopian Government has executed administrative actions and managed risk communications and community engagement. Risk Manag Healthc Policy. 2020;13:2803.33299368
   PubMed Web of Science ®Google Scholar
• TRACKER RC. Ethiopia: The Latest Coronavirus Counts, Charts and Maps; 2021.
   Google Scholar
• Dashraath P, Wong J, Lim M. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222(6):521–531. doi:10.1016/j.ajog.2020.03.02132217113
   PubMed Web of Science ®Google Scholar
• Ataguba J. COVID-19 pandemic, a war to be won: understanding its economic implications for Africa. Appl Health Econ Health Policy. 2020;18(3):325–328. doi:10.1007/s40258-020-00580-x32249362
   PubMed Web of Science ®Google Scholar
• Goyal P, Choi J, Pinheiro L. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372–2374. doi:10.1056/NEJMc201041932302078
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch J, Narasimhan M. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):20. doi:10.1001/jama.2020.6775
   Web of Science ®Google Scholar
• Fillmore NR, La J, Szalat RE, et al. Prevalence and outcome of COVID-19 infection in cancer patients: a national veterans affairs study. J Natl Cancer Inst. 2021;113(6):691–698. doi:10.1093/jnci/djaa15933031532
   PubMedGoogle Scholar
• Abdihamid O, Cai C, Kapesa L, Zeng S. The landscape of COVID-19 in cancer patients: prevalence, impacts, and recommendations. Cancer Manag Res. 2020;12:8923.33061588
   PubMed Web of Science ®Google Scholar
• Carreira H, Strongman H, Peppa M, McDonald HI, dos-Santos-Silva I, Stanway S. Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: a matched cohort study using linked English electronic health records data. EClinical Med. 2020;29:100656.
   Google Scholar
• England PH Guidance on shielding and protecting people defined on medical grounds as extremely vulnerable from COVID-19; 2020. Available from: https://wwwgovuk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19. Accessed November 6, 2021.
   Google Scholar
• Rogado J, Obispo B, Pangua C, et al. Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid. Clin Transl Oncol. 2020;22(12):2364–2368. doi:10.1007/s12094-020-02381-z32449128
   PubMed Web of Science ®Google Scholar
• ElGohary G, Hashmi S, Styczynski J, Kharfan-Dabaja M, Alblooshi R, Camara R. The risk and prognosis of COVID-19 infection in cancer patients: a systematic review and meta-analysis.. Hematol Oncol Stem Cell Ther. 2020;30:1658–3876.
   Google Scholar
• Brodziak A, Sigorski D, Osmola M, et al. Attitudes of patients with cancer towards vaccinations results of online survey with special focus on the vaccination against COVID-19. Vaccines. 2021;9:411.33919048
   PubMed Web of Science ®Google Scholar
• Patt D, Gordan L, Diaz M, et al. Impact of COVID-19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for American seniors. JCO Clin Cancer Inform. 2020;4:1059–1071. doi:10.1200/CCI.20.0013433253013
   PubMed Web of Science ®Google Scholar
• Dabi-Wake A. The willingness to receive covid-19 vaccine and its associated factors: “vaccination refusal could prolong the war of this pandemic” – a systematic review. Risk Manag Healthc Policy. 2021;14:2609–2623. doi:10.2147/RMHP.S31107434188572
   PubMed Web of Science ®Google Scholar
• Zingg A, Siegrist M. Measuring people’s knowledge about vaccination: developing a one-dimensional scale. Vaccines. 2021;30:25.
   Google Scholar
• Conte C, Sogni F, Affanni P, Veronesi L, Argentiero A, Esposito S. Vaccines against coronaviruses: the state of the art Vaccines. Vaccines . 2020;8(2):1–21. doi:10.3390/vaccines8020309
   Web of Science ®Google Scholar
• latest C-vtut. The New York Times. Available from: https://wwwnytimescom/interactive/2020/science/coronavirus-vaccinetrackerhtml. Accessed August 19, 2021.
   Google Scholar
• Frederiksen L, Zhang Y, Foged C, Thakur A. The long road toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies. Front Immunol. 2020;11:1817..32793245
   PubMed Web of Science ®Google Scholar
• Oncology ESoM. ESMO Statements for Vaccination against COVID-19 in Patients with Cancer; 2021. Available from: https://wwwesmoorg/covid-19-and-cancer/covid-19-vaccination. Accessed November 6, 2021.
   Google Scholar
• Oncology. ASoC. COVID-19 Vaccines & Patients with Cancer; 2021. Available FROM: https://wwwascoorg/asco-coronavirus-resources/covid-19-vaccines-patients-cancer. Accessed November 6, 2021.
   Google Scholar
• Singh L, Bansal S, Bode L., et al A first look at COVID-19 information and misinformation sharing on Twitter. ArXiv. 2020;arXiv:2003.13907v1. Preprint.
   Google Scholar
• Chun JY, Kim SI, Park EY, et al. Cancer patients’willingness to take COVID-19 vaccination: a nationwide multicenter survey in Korea. Cancers. 2021;13(3883):3883. doi:10.3390/cancers1315388334359783
   PubMed Web of Science ®Google Scholar
• Jones C, Jensen J, Scherr C, Brown N, Christy K, Weaver J. The health belief model as an explanatory framework in communication research: exploring parallel, serial, and moderated mediation. Health Commun. 2015;30(6):566–576. doi:10.1080/10410236.2013.87336325010519
   PubMed Web of Science ®Google Scholar
• Hermann A, Hall A, Proietto A. Using the health belief model to explore why women decide for or against the removal of their ovaries to reduce their risk of developing cancer. BMC Women’s Health. 2018;18(184). doi:10.1186/s12905-018-0673-2
   Web of Science ®Google Scholar
• Villarreal-Garza C, Vaca-Cartagena BF, Becerril-Gaitan A. Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer. JAMA Oncol. 2021;7(8):1242–1244. doi:10.1001/jamaoncol.2021.196234110371
   PubMed Web of Science ®Google Scholar
• Zewude B, Belachew A. Intention to receive the second round of COVID-19 vaccine among healthcare workers in Eastern Ethiopia. Infect Drug Resist. 2021;14:3071–3082. doi:10.2147/IDR.S32605534408451
   PubMed Web of Science ®Google Scholar
• Belsti Y, Yismaw-Gela Y, Akalu Y, et al. Willingness of Ethiopian population to receive COVID-19 vaccine. J Multidiscip Healthc. 2021;14:1233–1243. doi:10.2147/JMDH.S31263734093019
   PubMed Web of Science ®Google Scholar
• CDC. Certain Medical Conditions and Risk for Severe COVID-19 Illness; 2020. Available from: https://wwwcdcgov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditionshtml. Accessed August 10, 2021.
   Google Scholar
• Corti C, Crimini E, Tarantino P, Eggermont AMM, Delaloge S, Curigliano G. SARS-CoV-2 vaccines for cancer patients: a call to action. Eur j Cancer. 2021;148:316–327. doi:10.1016/j.ejca.2021.01.04633770576
   PubMed Web of Science ®Google Scholar
• Wang Q, Berger N, Xu R. When hematologic malignancies meet COVID-19 in the United States: infections, death and disparities. Blood Rev.2020;9:100775.
   Google Scholar
• Wang Q, Berger N, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol. 2020;7(2):220.
   Web of Science ®Google Scholar
• Johannesen TB, Smeland S, Aaserud S, et al. COVID-19 in cancer patients, risk factors for disease and adverse outcome, a population-based study from Norway. Cancer Epidemiol Prev. 2021. doi:10.3389/fonc.2021.652535
   Web of Science ®Google Scholar
• Yu J, Ouyang W, Kc ML, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020;6(7):1108. doi:10.1001/jamaoncol.2020.098032211820
   PubMed Web of Science ®Google Scholar
• Moujaess E, Zeid NB, Samaha R, et al. Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey. Fut Med. 2021. doi:10.2217/fon-021-0265
   Google Scholar
• Barrière J, Gal J, Hoch B. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Ann Oncol. 2021;32(5):673–674. doi:10.1016/j.annonc.2021.01.06633529740
   PubMed Web of Science ®Google Scholar
• Brodziak A, Sigorski D, Osmola M, et al. Attitudes of patients with cancer towards vaccinations-results of online survey with special focus on the vaccination against COVID-19. Vaccines. 2021;9(5):411.33919048
   PubMed Web of Science ®Google Scholar
• Wahed T, Kaukab S, Saha N. Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka, Bangladesh. BMC Public Health. 2013;13(1):242. doi:10.1186/471-2458-13-24223509860
   PubMed Web of Science ®Google Scholar
• Kwok KO, Li -K-K, WeI WI, Tang A, Wong SYS, Lee SS. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey. Int J Nurs Study. 2021;114:103854.
   PubMed Web of Science ®Google Scholar